US Stock MarketDetailed Quotes

Alto Neuroscience (ANRO)

Watchlist
  • 22.780
  • +0.380+1.70%
Close Apr 10 16:00 ET
  • 22.700
  • -0.080-0.35%
Post 19:54 ET
727.72MMarket Cap-10.40P/E (TTM)

Alto Neuroscience (ANRO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-3.27%66.36M
0.34%17.06M
-20.84%14.95M
1.86%18.68M
8.97%15.68M
81.46%68.61M
44.47%17M
94.34%18.89M
101.00%18.34M
99.78%14.39M
Selling and administrative expenses
-4.02%20.75M
-18.36%5.06M
-24.03%4.43M
7.78%5.56M
28.60%5.7M
187.50%21.61M
192.04%6.2M
232.72%5.83M
151.19%5.16M
178.52%4.43M
-General and administrative expense
-4.02%20.75M
-18.36%5.06M
-24.03%4.43M
7.78%5.56M
28.60%5.7M
187.50%21.61M
192.04%6.2M
232.72%5.83M
151.19%5.16M
178.52%4.43M
Research and development costs
-2.93%45.62M
11.07%12M
-19.41%10.53M
-0.46%13.12M
0.22%9.97M
55.15%47M
12.00%10.8M
63.93%13.06M
86.43%13.18M
77.43%9.95M
Operating profit
3.27%-66.36M
-0.34%-17.06M
20.84%-14.95M
-1.86%-18.68M
-8.97%-15.68M
-81.46%-68.61M
-44.47%-17M
-94.34%-18.89M
-101.00%-18.34M
-99.78%-14.39M
Net non-operating interest income expense
-44.70%4.13M
-45.28%986K
-59.00%882K
-55.13%1.04M
1.40%1.23M
663.64%7.48M
371.73%1.8M
512.82%2.15M
579.71%2.31M
1,389.36%1.21M
Non-operating interest income
-25.40%6.6M
-26.89%1.56M
-38.72%1.53M
-36.68%1.68M
17.27%1.83M
276.80%8.85M
189.30%2.14M
250.14%2.5M
298.50%2.66M
577.39%1.56M
Non-operating interest expense
79.56%2.47M
72.67%575K
86.25%650K
86.17%646K
72.83%598K
0.36%1.38M
-6.46%333K
-3.86%349K
6.12%347K
6.79%346K
Other net income (expense)
-239.39%-1.01M
-1,783.33%-113K
-133.33%-112K
-61K
-197.12%-722K
-156.57%-297K
-103.61%-6K
-121.24%-48K
-2,309.09%-243K
Gain on sale of security
----
----
----
----
----
----
----
----
----
-2,309.09%-243K
Special income (charges)
---681K
--0
--0
--0
---681K
--0
--0
--0
--0
--0
-Less:Other special charges
--681K
--0
----
----
--681K
----
----
----
----
----
Other non- operating income (expenses)
-10.10%-327K
-1,783.33%-113K
-133.33%-112K
---61K
83.13%-41K
-156.57%-297K
---6K
---48K
----
---243K
Income before tax
-2.94%-63.24M
-6.45%-16.18M
15.50%-14.18M
-10.46%-17.71M
-13.06%-15.17M
-69.21%-61.43M
-35.52%-15.2M
-83.60%-16.78M
-85.04%-16.03M
-84.20%-13.42M
Income tax
Net income
-2.94%-63.24M
-6.45%-16.18M
15.50%-14.18M
-10.46%-17.71M
-13.06%-15.17M
-69.21%-61.43M
-35.52%-15.2M
-83.60%-16.78M
-85.04%-16.03M
-84.20%-13.42M
Net income continuous Operations
-2.94%-63.24M
-6.45%-16.18M
15.50%-14.18M
-10.46%-17.71M
-13.06%-15.17M
-69.21%-61.43M
-35.52%-15.2M
-83.60%-16.78M
-85.04%-16.03M
-84.20%-13.42M
Minority interest income
Net income attributable to the parent company
-2.94%-63.24M
-6.45%-16.18M
15.50%-14.18M
-10.46%-17.71M
-13.06%-15.17M
-69.21%-61.43M
-35.52%-15.2M
-83.60%-16.78M
-85.04%-16.03M
-84.20%-13.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-2.94%-63.24M
-6.45%-16.18M
15.50%-14.18M
-10.46%-17.71M
-13.06%-15.17M
-69.21%-61.43M
-35.52%-15.2M
-83.60%-16.78M
-85.04%-16.03M
-84.20%-13.42M
Basic earnings per share
12.40%-2.19
20.11%-0.45
16.13%-0.52
-8.33%-0.65
26.32%-0.56
-76.11%-2.5
-28.43%-0.5633
-73.46%-0.62
-77.13%-0.6
-35.43%-0.76
Diluted earnings per share
12.40%-2.19
20.11%-0.45
16.13%-0.52
-8.33%-0.65
26.32%-0.56
-76.11%-2.5
-28.43%-0.5633
-73.46%-0.62
-77.13%-0.6
-35.43%-0.76
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -3.27%66.36M0.34%17.06M-20.84%14.95M1.86%18.68M8.97%15.68M81.46%68.61M44.47%17M94.34%18.89M101.00%18.34M99.78%14.39M
Selling and administrative expenses -4.02%20.75M-18.36%5.06M-24.03%4.43M7.78%5.56M28.60%5.7M187.50%21.61M192.04%6.2M232.72%5.83M151.19%5.16M178.52%4.43M
-General and administrative expense -4.02%20.75M-18.36%5.06M-24.03%4.43M7.78%5.56M28.60%5.7M187.50%21.61M192.04%6.2M232.72%5.83M151.19%5.16M178.52%4.43M
Research and development costs -2.93%45.62M11.07%12M-19.41%10.53M-0.46%13.12M0.22%9.97M55.15%47M12.00%10.8M63.93%13.06M86.43%13.18M77.43%9.95M
Operating profit 3.27%-66.36M-0.34%-17.06M20.84%-14.95M-1.86%-18.68M-8.97%-15.68M-81.46%-68.61M-44.47%-17M-94.34%-18.89M-101.00%-18.34M-99.78%-14.39M
Net non-operating interest income expense -44.70%4.13M-45.28%986K-59.00%882K-55.13%1.04M1.40%1.23M663.64%7.48M371.73%1.8M512.82%2.15M579.71%2.31M1,389.36%1.21M
Non-operating interest income -25.40%6.6M-26.89%1.56M-38.72%1.53M-36.68%1.68M17.27%1.83M276.80%8.85M189.30%2.14M250.14%2.5M298.50%2.66M577.39%1.56M
Non-operating interest expense 79.56%2.47M72.67%575K86.25%650K86.17%646K72.83%598K0.36%1.38M-6.46%333K-3.86%349K6.12%347K6.79%346K
Other net income (expense) -239.39%-1.01M-1,783.33%-113K-133.33%-112K-61K-197.12%-722K-156.57%-297K-103.61%-6K-121.24%-48K-2,309.09%-243K
Gain on sale of security -------------------------------------2,309.09%-243K
Special income (charges) ---681K--0--0--0---681K--0--0--0--0--0
-Less:Other special charges --681K--0----------681K--------------------
Other non- operating income (expenses) -10.10%-327K-1,783.33%-113K-133.33%-112K---61K83.13%-41K-156.57%-297K---6K---48K-------243K
Income before tax -2.94%-63.24M-6.45%-16.18M15.50%-14.18M-10.46%-17.71M-13.06%-15.17M-69.21%-61.43M-35.52%-15.2M-83.60%-16.78M-85.04%-16.03M-84.20%-13.42M
Income tax
Net income -2.94%-63.24M-6.45%-16.18M15.50%-14.18M-10.46%-17.71M-13.06%-15.17M-69.21%-61.43M-35.52%-15.2M-83.60%-16.78M-85.04%-16.03M-84.20%-13.42M
Net income continuous Operations -2.94%-63.24M-6.45%-16.18M15.50%-14.18M-10.46%-17.71M-13.06%-15.17M-69.21%-61.43M-35.52%-15.2M-83.60%-16.78M-85.04%-16.03M-84.20%-13.42M
Minority interest income
Net income attributable to the parent company -2.94%-63.24M-6.45%-16.18M15.50%-14.18M-10.46%-17.71M-13.06%-15.17M-69.21%-61.43M-35.52%-15.2M-83.60%-16.78M-85.04%-16.03M-84.20%-13.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -2.94%-63.24M-6.45%-16.18M15.50%-14.18M-10.46%-17.71M-13.06%-15.17M-69.21%-61.43M-35.52%-15.2M-83.60%-16.78M-85.04%-16.03M-84.20%-13.42M
Basic earnings per share 12.40%-2.1920.11%-0.4516.13%-0.52-8.33%-0.6526.32%-0.56-76.11%-2.5-28.43%-0.5633-73.46%-0.62-77.13%-0.6-35.43%-0.76
Diluted earnings per share 12.40%-2.1920.11%-0.4516.13%-0.52-8.33%-0.6526.32%-0.56-76.11%-2.5-28.43%-0.5633-73.46%-0.62-77.13%-0.6-35.43%-0.76
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More